Can a tiny stent tame brain aneurysms?

NCT ID NCT07761598

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial is testing a new medical device called FRED X, designed to treat brain aneurysms—weak spots in blood vessels that can bulge and potentially rupture. The study will enroll about 15 people with a single untreated aneurysm to see if the device, used with blood-thinning medication, can safely block blood flow to the aneurysm and prevent complications like blood clots. The main goal is to check how safe and feasible the device is in a small group of patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
FRED X, a medical device (flow diverter stent) used with dual antiplatelet therapy (DAPT) to treat cerebral aneurysms
What this could lead to
If successful, this could provide a safer, more effective way to treat brain aneurysms, reducing the risk of rupture and stroke.
What could go wrong
This is an early feasibility study with a small number of participants, so results may not apply broadly. Risks include blood clots, bleeding, or complications from the device or medication.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEURYSM CEREBRAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Jacobs Institute

    Buffalo, New York, 14203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.